Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Professional Survey Report 2019

Publisher Name :
Date: 08-Nov-2019
No. of pages: 110
Inquire Before Buying

The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall B-Cell Maturation Antigen(BCMA) Targeted Therapies market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of B-Cell Maturation Antigen(BCMA) Targeted Therapies in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their B-Cell Maturation Antigen(BCMA) Targeted Therapies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

- Transposagen Biopharmaceuticals

- Sutro Biopharma

- Malin Corporation

- Eureka Therapeutics

- firstVentury Equity

- Five Prime Therapeutics

- Credit Suisse Securities

- Dana-Farber Cancer Institute

- Deerfield Partners

- Onyx Pharmaceuticals

- Juno Therapeutics

Segment by Regions

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Segment by Type

- Bispecific Antibodies

- Antibody Drug Conjugates

- Chimeric Antigen Receptor T-Cells

Segment by Application

- Liver Cancer

- Respiratory Cancer

- Brain Cancer

- Others

Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of B-Cell Maturation Antigen(BCMA) Targeted Therapies
1.1 Definition of B-Cell Maturation Antigen(BCMA) Targeted Therapies
1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment by Type
1.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Bispecific Antibodies
1.2.3 Antibody Drug Conjugates
1.2.4 Chimeric Antigen Receptor T-Cells
1.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment by Applications
1.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Comparison by Applications (2014-2025)
1.3.2 Liver Cancer
1.3.3 Respiratory Cancer
1.3.4 Brain Cancer
1.3.5 Others
1.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Overall Market
1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2014-2025)
1.4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (2014-2025)
1.4.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.5 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.6 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.7 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
1.4.8 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
2.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
2.4 Industry Chain Structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies
3 Development and Manufacturing Plants Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
3.1 Capacity and Commercial Production Date
3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of B-Cell Maturation Antigen(BCMA) Targeted Therapies
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Production and Capacity Analysis
4.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Analysis
4.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Analysis
4.4 Market Concentration Degree
5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Regional Market Analysis
5.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Regions
5.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Regions
5.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Regions
5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Regions
5.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.3.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.3.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.4.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.4.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.5 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.5.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.5.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.5.3 Key Manufacturers in China
5.5.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.6 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.6.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.6.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.7 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.7.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.7.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
5.8 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis
5.8.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production
5.8.2 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
5.8.3 Key Manufacturers in India
5.8.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export
6 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment Market Analysis (by Type)
6.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Type
6.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Type
6.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Price by Type
7 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment Market Analysis (by Application)
7.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Application
7.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Share by Application (2014-2019)
8 B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers Analysis
8.1 Transposagen Biopharmaceuticals
8.1.1 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.1.2 Transposagen Biopharmaceuticals Product Introduction, Application and Specification
8.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sutro Biopharma
8.2.1 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.2.2 Sutro Biopharma Product Introduction, Application and Specification
8.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Malin Corporation
8.3.1 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.3.2 Malin Corporation Product Introduction, Application and Specification
8.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eureka Therapeutics
8.4.1 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.4.2 Eureka Therapeutics Product Introduction, Application and Specification
8.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 firstVentury Equity
8.5.1 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.5.2 firstVentury Equity Product Introduction, Application and Specification
8.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Five Prime Therapeutics
8.6.1 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.6.2 Five Prime Therapeutics Product Introduction, Application and Specification
8.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Credit Suisse Securities
8.7.1 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.7.2 Credit Suisse Securities Product Introduction, Application and Specification
8.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Dana-Farber Cancer Institute
8.8.1 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.8.2 Dana-Farber Cancer Institute Product Introduction, Application and Specification
8.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Deerfield Partners
8.9.1 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.9.2 Deerfield Partners Product Introduction, Application and Specification
8.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Onyx Pharmaceuticals
8.10.1 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
8.10.2 Onyx Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Juno Therapeutics
9 Development Trend of Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
9.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend Analysis
9.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Volume and Value) Forecast 2019-2025
9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Regional Market Trend
9.2.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.5 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.2.6 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecast 2019-2025
9.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend (Product Type)
9.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Types in 2018
Figure Bispecific Antibodies Product Picture
Figure Antibody Drug Conjugates Product Picture
Figure Chimeric Antigen Receptor T-Cells Product Picture
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Share by Applications in 2018
Figure Liver Cancer
Figure Respiratory Cancer
Figure Brain Cancer
Figure Others
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) (2014-2025)
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) (2014-2025)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Million USD) (2014-2025)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies in 2018
Figure Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Industry Chain Structure of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Plants Distribution
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity (K Units) of Major Manufacturers (2014-2019)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) of Major Manufacturers (2014-2019)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Share by Manufacturers in 2018
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million US$) of Major Manufacturers (2014-2019)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share of Major Manufacturers (2014-2019)
Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Share by Manufacturers in 2018
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production by Regions 2014-2019 (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Regions 2014-2019
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Regions in 2018
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Regions 2014-2019 (Million USD)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Regions 2014-2019
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Regions in 2018
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Regions 2014-2019 (K Units)
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Share by Regions 2014-2019
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate 2014-2019 (K Units)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate 2014-2019 (Million USD)
Table India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption Import and Export (K Units)
Figure Global Consumption B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2014-2019)
Figure Global Value (Consumption) B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Introduction, Application and Specification
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate (2014-2019)
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share (2014-2019)
Figure Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share (2014-2019)
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Sites and Area Served
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production (K Units) Growth Rate Forecast 2019-2025
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price (USD/Unit) Forecast 2019-2025
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth Rate Forecast 2019-2025 (K Units)
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Type (2019-2025)
Table Global Consumption (K Units) of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application (2019-2025)
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Distributors List
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Parenteral Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 13-Nov-2019        Price: US 3480 Onwards        Pages: 118
    Scope of the Report: The worldwide market for Parenteral Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Parenteral Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and app......
  • Global Dabigatran Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 13-Nov-2019        Price: US 3480 Onwards        Pages: 101
    Scope of the Report: The global Dabigatran market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might ......
  • Global Cannabis Concentrate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 13-Nov-2019        Price: US 3480 Onwards        Pages: 102
    Scope of the Report: The worldwide market for Cannabis Concentrate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cannabis Concentrate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type......
  • Global Medicated Shampoo Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 13-Nov-2019        Price: US 3480 Onwards        Pages: 109
    Scope of the Report: The worldwide market for Medicated Shampoo is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Medicated Shampoo in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and a......
  • Global Packaged Fluoride Varnish Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 13-Nov-2019        Price: US 3480 Onwards        Pages: 109
    Scope of the Report: The worldwide market for Packaged Fluoride Varnish is expected to grow at a CAGR of roughly 3.4% over the next five years, will reach 157.9 million US$ in 2024, from 137.9 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Packaged Fluoride Varnish in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacture......
  • Global Topical Fluoride Therapy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 13-Nov-2019        Price: US 3480 Onwards        Pages: 119
    Scope of the Report: The worldwide market for Topical Fluoride Therapy is expected to grow at a CAGR of roughly 3.3% over the next five years, will reach 147.9 million US$ in 2024, from 129.6 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Topical Fluoride Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers......
  • Global Pharma & Cosmetics Market Growth 2019-2024
    Published: 13-Nov-2019        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Pharma & Cosmetics market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 1742660 million by 2024, from US$ 1524970 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pharma & Cosmetics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pharma & Cosmetics ma......
  • Global IVIg Powder Market Professional Survey Report 2019
    Published: 12-Nov-2019        Price: US 3500 Onwards        Pages: 111
    The global IVIg Powder market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on IVIg Powder volume and value at global level, regional level and company level. From a global perspective, this report represents overall IVIg Powder market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import o......
  • Global High Purity Milk Protein Concentrate Market Professional Survey Report 2019
    Published: 12-Nov-2019        Price: US 3500 Onwards        Pages: 111
    The global High Purity Milk Protein Concentrate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Purity Milk Protein Concentrate volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Purity Milk Protein Concentrate market size by analyzing historical data and future prospect. Regionally, this r......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs